Pembrolizumab and EDP1503 in Advanced Melanoma

NCT03595683 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Drug supply no longer available.

Conditions

Melanoma (Skin)
Melanoma

Interventions

DRUG: Pembrolizumab
BIOLOGICAL: EDP1503

Sponsor

University of Chicago

Collaborators

Merck Sharp & Dohme LLC
Evelo Biosciences, Inc.